These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20876189)

  • 1. A randomized trial of viral hepatitis prevention among underprivileged people in the Lyon area of France.
    Sahajian F; Bailly F; Vanhems P; Fantino B; Vannier-Nitenberg C; Fabry J; Trepo C;
    J Public Health (Oxf); 2011 Jun; 33(2):182-92. PubMed ID: 20876189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening campaign of hepatitis C among underprivileged people consulting in health centres of Lyon area, France.
    Sahajian F; Vanhems P; Bailly F; Fabry J; Trepo C; Sepetjan M
    Eur J Public Health; 2007 Jun; 17(3):263-71. PubMed ID: 17068003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C and B testing in English prisons is low but increasing.
    Kirwan P; Evans B; ; Brant L
    J Public Health (Oxf); 2011 Jun; 33(2):197-204. PubMed ID: 21345883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and C seroprevalence in the Lebanese population.
    Baddoura R; Haddad C; Germanos M
    East Mediterr Health J; 2002 Jan; 8(1):150-6. PubMed ID: 15330570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-HB-core antibodies as a surrogate marker in blood donors].
    Blejer JL; Saguier MC; Salamone HJ
    Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
    [No Abstract]   [Full Text] [Related]  

  • 6. Is screening for hepatitis B and hepatitis C useful in patients with recent-onset polyarthritis? The ESPOIR cohort study.
    Guennoc X; Narbonne V; Jousse-Joulin S; Devauchelle-Pensec V; Dougados M; Daurès JP; Saraux A
    J Rheumatol; 2009 Jul; 36(7):1407-13. PubMed ID: 19531755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevalence of infection by hepatitis viruses in a rural area. Analysis according to risk factors and alcohol consumption].
    Nalpas B; Zylberberg H; Dubois F; Presles MA; Gillant JC; Lienard M; Delemotte B; Bréchot C
    Gastroenterol Clin Biol; 2000 May; 24(5):536-40. PubMed ID: 10891742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
    Meffre C; Le Strat Y; Delarocque-Astagneau E; Dubois F; Antona D; Lemasson JM; Warszawski J; Steinmetz J; Coste D; Meyer JF; Leiser S; Giordanella JP; Gueguen R; Desenclos JC
    J Med Virol; 2010 Apr; 82(4):546-55. PubMed ID: 20166185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of transmission of hepatitis B, hepatitis C and human immunodeficiency virus infections through blood transfusion by anti-HBc testing.
    Busch MP
    Vox Sang; 1998; 74 Suppl 2():147-54. PubMed ID: 9704438
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hepatitis B, C, and E in New Caledonia. Seroepidemiologic study in military recruits].
    Bauduceau O; Berlioz A; Buisson Y
    Med Trop (Mars); 2000; 60(2):167-70. PubMed ID: 11100445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Should hepatitis C be screened? Analysis of oriented screening strategies for hepatitis C virus infection].
    Desenclos JC; Dubois F; Mariotte N; Goudeau A
    Gastroenterol Clin Biol; 1997; 21(1 Pt 2):S25-32. PubMed ID: 9161511
    [No Abstract]   [Full Text] [Related]  

  • 12. Transfusion-transmitted hepatitis virus infection.
    Dodd RY
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroepidemiology of hepatitis B virus markers among hospital health care workers. Analysis of certain potential risk factors.
    Daw MA; Siala IM; Warfalli MM; Muftah MI
    Saudi Med J; 2000 Dec; 21(12):1157-60. PubMed ID: 11360090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of antenatal screening for hepatitis B among pregnant women in Denmark].
    Jensen L; Heilmann CJ; Smith E; Wantzin PS; Peitersen B; Weber T; Krogsgaard K
    Ugeskr Laeger; 2004 Sep; 166(38):3303-5. PubMed ID: 15496008
    [No Abstract]   [Full Text] [Related]  

  • 15. Relative safety of first-time volunteer and replacement donors in West Africa.
    Allain JP; Sarkodie F; Asenso-Mensah K; Owusu-Ofori S
    Transfusion; 2010 Feb; 50(2):340-3. PubMed ID: 19843284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
    Ghavanini AA; Sabri MR
    East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medico-social aspects in the prevention of viral hepatitis B and C in young people and adolescents].
    Martova OV; Sal'ko VN; Boĭko ; Akhmerova RR; Lukashina DF
    Gig Sanit; 2002; (1):45-7. PubMed ID: 11899873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Viral hepatitis in the field of dentistry. I. The risk for health workers].
    Nardi G
    Minerva Stomatol; 1982; 31(6):743-53. PubMed ID: 6819437
    [No Abstract]   [Full Text] [Related]  

  • 20. [Vaccination against hepatitis B. The 1988-1991 experience at Local Health District 9, Lombardy].
    Gariboldi G
    Ann Ig; 1993; 5(3):199-205. PubMed ID: 7513177
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.